DT Investment Partners’s BioNTech BNTX Stock Holding History

DT Investment Partners’s Portfolio BNTX Stock Details BNTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-500	Closed	-$44.4K	–	515
2026 Q1	$44.4K	Hold	500	–	–	﹤0.01%	252
2025 Q4	$47.6K	Hold	500	–	–	﹤0.01%	254
2025 Q3	$49.3K	Hold	500	–	–	﹤0.01%	239
2025 Q2	$53.2K	Hold	500	–	–	﹤0.01%	229
2025 Q1	$45.5K	Hold	500	–	–	﹤0.01%	237
2024 Q4	$57K	Hold	500	–	–	﹤0.01%	224
2024 Q3	$59.4K	Hold	500	–	–	﹤0.01%	233
2024 Q2	$40.2K	Hold	500	–	–	﹤0.01%	255
2024 Q1	$46.1K	Hold	500	–	–	﹤0.01%	232
2023 Q4	$47.5K	Hold	500	–	–	0.01%	226
2023 Q3	$54.3K	Hold	500	–	–	0.01%	199
2023 Q2	$53.6K	Hold	500	–	–	0.01%	207
2023 Q1	$56K	Hold	500	–	–	0.01%	200
2022 Q4	$75.1K	Hold	500	–	–	0.01%	184
2022 Q3	$67K	Buy	+500	New	+$76.4K	0.01%	183

Other funds holding BNTX

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Flossbach Von Storch Cologne, Germany $22.1B AUM 6.81% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

GSK plc London $602M AUM

DT Investment Partners's BNTX Position: Q2 2026 in Review

DT Investment Partners sold out of BioNTech (BNTX) in Q2 2026, closing a stake of 500 shares — an estimated $44.4K sold.

DT Investment Partners first reported a position in BNTX in Q3 2022 and held it in 15 quarters. The position peaked at $75.1K in Q4 2022. 282 funds tracked by Wall St. Rank hold BNTX as of Q2 2026.

DT Investment Partners reported no remaining BioNTech position as of Q2 2026 after selling out during the quarter.
DT Investment Partners sold 500 BioNTech shares in Q2 2026, an estimated $44.4K.
DT Investment Partners first reported a position in BioNTech in Q3 2022 and held it in 15 quarters.
DT Investment Partners's BioNTech position peaked at $75.1K in Q4 2022.
282 funds tracked by Wall St. Rank held BioNTech as of Q2 2026.

Based on DT Investment Partners's 13F filing for Q2 2026, filed 27 Jul 2026.